CME Group (CME) Projected to Post Earnings on Wednesday

CME Group (NASDAQ:CMEGet Free Report) is projected to announce its Q3 2025 results before the market opens on Wednesday, October 22nd. Analysts expect the company to announce earnings of $2.73 per share and revenue of $1.5621 billion for the quarter. Individuals may visit the the company’s upcoming Q3 2025 earningresults page for the latest details on the call scheduled for Wednesday, October 22, 2025 at 8:30 AM ET.

CME Group (NASDAQ:CMEGet Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The financial services provider reported $2.96 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.91 by $0.05. CME Group had a return on equity of 14.60% and a net margin of 58.48%.The company had revenue of $1.69 billion during the quarter, compared to the consensus estimate of $1.68 billion. During the same period in the previous year, the business earned $2.56 EPS. CME Group’s revenue for the quarter was up 10.4% on a year-over-year basis. On average, analysts expect CME Group to post $10 EPS for the current fiscal year and $11 EPS for the next fiscal year.

CME Group Trading Up 2.1%

CME opened at $267.93 on Monday. The company has a debt-to-equity ratio of 0.12, a quick ratio of 1.02 and a current ratio of 1.02. CME Group has a one year low of $213.94 and a one year high of $290.79. The company has a market cap of $96.56 billion, a P/E ratio of 25.94, a PEG ratio of 6.16 and a beta of 0.41. The business’s 50-day simple moving average is $267.30 and its 200-day simple moving average is $271.40.

CME Group Announces Dividend

The business also recently declared a quarterly dividend, which was paid on Thursday, September 25th. Shareholders of record on Tuesday, September 9th were paid a $1.25 dividend. This represents a $5.00 annualized dividend and a yield of 1.9%. The ex-dividend date was Tuesday, September 9th. CME Group’s dividend payout ratio is currently 48.40%.

Wall Street Analysts Forecast Growth

Several analysts have recently weighed in on CME shares. Oppenheimer boosted their price objective on shares of CME Group from $300.00 to $303.00 and gave the stock an “outperform” rating in a research report on Thursday, July 24th. Citigroup raised shares of CME Group from a “neutral” rating to a “buy” rating and boosted their price target for the company from $275.00 to $300.00 in a research report on Thursday, September 25th. Deutsche Bank Aktiengesellschaft decreased their price objective on shares of CME Group from $276.00 to $266.00 and set a “hold” rating for the company in a research note on Thursday, October 9th. Jefferies Financial Group cut their target price on CME Group from $313.00 to $304.00 and set a “buy” rating on the stock in a research report on Friday, October 10th. Finally, Raymond James Financial decreased their target price on CME Group from $309.00 to $307.00 and set an “outperform” rating for the company in a research report on Monday, October 13th. Seven research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and two have given a Sell rating to the company’s stock. According to MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $283.71.

Get Our Latest Research Report on CME Group

Insider Buying and Selling at CME Group

In other news, General Counsel Jonathan L. Marcus sold 392 shares of the company’s stock in a transaction dated Thursday, September 18th. The shares were sold at an average price of $262.00, for a total value of $102,704.00. Following the completion of the sale, the general counsel directly owned 7,851 shares of the company’s stock, valued at approximately $2,056,962. This represents a 4.76% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Sunil Cutinho sold 11,896 shares of the firm’s stock in a transaction dated Tuesday, August 26th. The stock was sold at an average price of $271.47, for a total value of $3,229,407.12. Following the transaction, the insider directly owned 17,440 shares in the company, valued at approximately $4,734,436.80. This represents a 40.55% decrease in their position. The disclosure for this sale can be found here. In the last three months, insiders have sold 13,043 shares of company stock valued at $3,527,956. Company insiders own 0.30% of the company’s stock.

Institutional Investors Weigh In On CME Group

Large investors have recently modified their holdings of the stock. ICW Investment Advisors LLC raised its stake in CME Group by 6.3% in the second quarter. ICW Investment Advisors LLC now owns 1,304 shares of the financial services provider’s stock worth $359,000 after buying an additional 77 shares in the last quarter. Keel Point LLC boosted its position in CME Group by 9.8% during the 2nd quarter. Keel Point LLC now owns 1,423 shares of the financial services provider’s stock valued at $392,000 after acquiring an additional 127 shares in the last quarter. Sompo Asset Management Co. Ltd. grew its holdings in shares of CME Group by 5.5% during the 2nd quarter. Sompo Asset Management Co. Ltd. now owns 2,490 shares of the financial services provider’s stock worth $686,000 after acquiring an additional 130 shares during the period. Modern Wealth Management LLC raised its position in shares of CME Group by 1.4% in the 2nd quarter. Modern Wealth Management LLC now owns 12,544 shares of the financial services provider’s stock worth $3,457,000 after acquiring an additional 174 shares in the last quarter. Finally, Smartleaf Asset Management LLC lifted its stake in shares of CME Group by 4.0% in the 2nd quarter. Smartleaf Asset Management LLC now owns 4,662 shares of the financial services provider’s stock valued at $1,281,000 after purchasing an additional 178 shares during the period. Hedge funds and other institutional investors own 87.75% of the company’s stock.

CME Group Company Profile

(Get Free Report)

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.

Featured Stories

Earnings History for CME Group (NASDAQ:CME)

Receive News & Ratings for CME Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CME Group and related companies with MarketBeat.com's FREE daily email newsletter.